Genedrive signals potential £1m loan from shareholder David Nugent.
AIM-listed Genedrive said on Friday that shareholder David Nugent had shown "willingness" to make a cash injection into the point-of-care pharmacogenetic testing company.
Genedrive
31 October 2025 10:14:31
Source: Sharecast
The company said that since its general meeting on 15 October, it has "continued to engage constructively" with Nugent - who has a 16% interest in the group - about financing options.
Genedrive said Nugent "has recently indicated a willingness" to make a direct cash injection into the company by way of a loan of up to £1m on terms to be agreed between the parties.
"Whilst there can be no certainty that this additional funding will be received the company welcomes this indication of potential additional financial support from David Nugent and further announcements will be made in due course," it said.
At 1010 GMT, the shares were up 10% at 0.94p.
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
